Evaluation of Intraoperative Microwave Coagulo-necrotic Therapy (MCN) for Hepatocellular Carcinoma: a Single Center Experience of 719 Consecutive Cases

Overview

Journal J Hepatobiliary Pancreat Sci

Date 2012 Jun 20

PMID 22710886

Citations 24

Authors

Yuko Takami

Tomoki Ryu

Yoshiyuki Wada

Hideki Saitsu

Affiliations

Soon will be listed here.

Abstract

Background: Hepatic resection (HRx) or radiofrequency ablation may be carried out as the first-line treatment of hepatocellular carcinoma (HCC). However, we have used intraoperative microwave ablation, named microwave coagulo-necrotic therapy (MCN) as part of our strategy for the treatment of HCCs for more than 15 years. Here we describe the treatment outcomes achieved at our institution as a high-volume center for microwave ablation.

Methods: Between July 1994 and December 2010, 719 consecutive patients received MCN as their initial therapy for HCC (mean tumor size 26.9 mm, mean number of lesions 2.51) at our institute. The therapeutic survival effect, local tumor progression, and overall recurrence were prospectively evaluated and statistically analyzed.

Results: The 1-, 3-, 5-, 7-, and 10-year overall survival rates of all 719 patients were 97.7, 79.8, 62.1, 45.3, and 34.1 %, respectively. Thirty percent of the patients had Child-Pugh class B cirrhosis and the 5-year survival rate of these patients was 46.6 %. The 5-year survival of patients with ≥4 lesions (n = 168) was 49.6 % and that of patients meeting the Milan criteria (n = 470) was 70.9 %. The 1-, 3-, 5-, 7-, and 10-year overall survival rates for 390 patients treated with MCN who had ≤3 lesions with diameter ≤3 cm were 97.9, 85.1, 70.0, 57.1, and 43.0 %. No significant differences were found between the overall survival rates after MCN and the overall survival rates in 34 patients treated with HRx during the same period at our institute and under the same (P = 0.3592), nor were there any differences in disease-free survival (P = 0.3496) and local recurrence rates between the MCN and HRx groups (P = 0.5926).

Conclusion: MCN is effective for the locoregional control of HCC, with results comparable to those of HRx. MCN should be considered as one of the first-choice treatments for HCC, even for patients with poor liver function or multiple lesions.

Citing Articles

Laparoscopic-assisted microwave ablation in treatment of small hepatocellular carcinoma: safety and efficacy in comparison with laparoscopic hepatectomy.

Wei Y, Zhang L, Zhang S, Song M, Ji C BMC Surg. 2024; 24(1):138.

PMID: 38715071 PMC: 11075224. DOI: 10.1186/s12893-024-02432-0.

HPB ultrasound guidance techniques - Targeting.

Strand M, Iannitti D Surg Open Sci. 2024; 19:50-62.

PMID: 38585037 PMC: 10995864. DOI: 10.1016/j.sopen.2024.02.013.

Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.

Wade R, South E, Anwer S, Sharif-Hurst S, Harden M, Fulbright H Health Technol Assess. 2023; 27(29):1-172.

PMID: 38149643 PMC: 11017143. DOI: 10.3310/GK5221.

Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma.

Dong T, Wang L, Li M, Yin C, Li Y, Nie F J Hepatocell Carcinoma. 2023; 10:733-743.

PMID: 37215363 PMC: 10198179. DOI: 10.2147/JHC.S409011.

Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity....

Huang Y, Xu L, Huang M, Jiang L, Xu M Cancer Med. 2023; 12(8):9213-9227.

PMID: 36722129 PMC: 10166907. DOI: 10.1002/cam4.5662.

References

Saitsu H, Yoshida M, Taniwaki S, Sato H, Okami N, Matsumoto A . [Laparoscopic coagulo-necrotic therapy using microtase for small hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi. 1991; 88(10):2727. View

Kotoh K, Morizono S, Kohjima M, Enjoji M, Sakai H, Nakamuta M . Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model. Liver Int. 2005; 25(6):1217-23. DOI: 10.1111/j.1478-3231.2005.01167.x. View

Liang P, Wang Y . Microwave ablation of hepatocellular carcinoma. Oncology. 2007; 72 Suppl 1:124-31. DOI: 10.1159/000111718. View

Pearson A, Izzo F, Fleming R, Ellis L, Delrio P, Roh M . Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 2000; 178(6):592-9. DOI: 10.1016/s0002-9610(99)00234-2. View

Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H . Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol. 2001; 31(7):322-6. DOI: 10.1093/jjco/hye063. View

Takada Y, Kurata M, Ohkohchi N . Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol. 2003; 8(5):332-5. DOI: 10.1007/s10147-003-0328-6. View

Lencioni R, Allgaier H, Cioni D, Olschewski M, Deibert P, Crocetti L . Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003; 228(1):235-40. DOI: 10.1148/radiol.2281020718. View

Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J . Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer. 2002; 95(9):1931-7. DOI: 10.1002/cncr.10892. View

Nkontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, Coderc E . Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology. 2009; 50(5):1475-83. DOI: 10.1002/hep.23181. View

10.

Ruzzenente A, De Manzoni G, Molfetta M, Pachera S, Genco B, Donataccio M . Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol. 2004; 10(8):1137-40. PMC: 4656348. DOI: 10.3748/wjg.v10.i8.1137. View

11.

Llovet J, Vilana R, Bru C, Bianchi L, Salmeron J, Boix L . Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001; 33(5):1124-9. DOI: 10.1053/jhep.2001.24233. View

12.

Kawamoto C, Yamauchi A, Baba Y, Kaneko K, Yakabi K . Measurement of intrahepatic pressure during radiofrequency ablation in porcine liver. J Gastroenterol. 2009; 45(4):435-42. DOI: 10.1007/s00535-009-0156-1. View

13.

Liang P, Wang Y, Yu X, Dong B . Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology. 2009; 251(3):933-40. DOI: 10.1148/radiol.2513081740. View

14.

Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T . Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006; 131(2):461-9. DOI: 10.1053/j.gastro.2006.05.021. View

15.

Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K . Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002; 223(2):331-7. DOI: 10.1148/radiol.2232010775. View

16.

Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C . Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?. Hepatology. 2007; 47(1):82-9. DOI: 10.1002/hep.21933. View

17.

Kudo M, Chung H, Osaki Y . Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003; 38(3):207-15. DOI: 10.1007/s005350300038. View

18.

Tabuse K . A new operative procedure of hepatic surgery using a microwave tissue coagulator. Nihon Geka Hokan. 1979; 48(2):160-72. View

19.

Martin R, Scoggins C, McMasters K . Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2009; 17(1):171-8. DOI: 10.1245/s10434-009-0686-z. View

20.

Bhardwaj N, Strickland A, Ahmad F, El-Abassy M, Morgan B, Robertson G . Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol. 2009; 36(3):264-8. DOI: 10.1016/j.ejso.2009.10.006. View